Join NDJworld     NDJ World On Facebook NDJ World On Twitter  NDJ World Free RSS Feeds  
  Text Only Site    Horror Files     StarHoopla

Jul 20 2010      ↓Who Said What   

Avastin, a drug primarily created by Roche to combat colon cancer showed tremendous promise for treating breast cancer as well. Yet the Food and Drug Administration has withdrawn its approval for the drug as a breast cancer medication 12 to 1 on grounds that Avastin, while promising, doesn’t really extend a patient’s life.

After more testing, it was said on Friday that the drug was not proven to extend women’s lives any more than other cancer treatments, such as chemotherapy.

Visit msnbc.com for breaking news, world news, and news about the economy

Avastin was originally given tentative approval as a drug to treat breast cancer when initial studies showed that the drug slowed the disease progress by a few months. The drug however did fail to proof that it also extended life.

According to Forbes:
“What really matters for a cancer drug is whether it helps the patient live longer. But those studies are very hard to do and take years. That’s why drug companies want to get drugs approved based on what are known as surrogate endpoints: Does the drug slow progression of the disease on a scan? Does it shrink tumors? But pretty-looking scans aren’t guaranteed to translate into fewer deaths. Maybe the disease will come back faster once the drug is stopped.”

Avastin not approved as breast cancer drug

A final decision will be made by the FDA after September 17 2010, when the FDA expects to receive the advisory panel’s recommendation regarding Avastin.

We understand the FDA’s position that life is a treasured commodity that must be preserved as long as possible. Still, to deny breast cancer patients, and for that matter, any other seriously ill individual, access to medications that possibly slows down the progress of this dreaded disease would be an injustice to those patients as they undoubtedly welcome any treatment that helps them with this awful illness, even if only a little bit.


 Share This:


3 Responses to “FDA Rejects Breast Cancer Drug Avastin”

  1. [...] » FDA Rejects Breast Cancer Drug Avastin [...]

  2. [...] FDA Rejects Breast Cancer Drug Avastin – Nodeju.com Logo [...]

  3. [...] NDJ World | News Hot Trends and Views [...]

What's Your Opinion?

You must be logged in to post a comment.


Got A Story? Email it to our news desk at Tip Line @ Nodeju.com


Patient Catches On Fire During Surgery

New York – During a tracheotomy procedure at the Lincoln hospital in New York, the head surgeon accidentally put the patient’s head on fire. When 52 year old Enrique Ruiz was placed on the surgery >> Full story

Premature Births In U.S. Equal To Africa

NEW YORK – Each year, 15 million babies are born prematurely worldwide and the United States has fared badly in the first global comparison of premature births, released by the World Health >> Full story


The Real Life Case of Benjamin Button

LONDON – Actor Brad Pitt may have only been playing the character of a man growing younger in the film ‘The Curious Case of Benjamin Button’ but in the United Kingdom, two brothers are actually >> Full story


Obese America Is Costing Taxpayers Dearly

WASHINGTON – From over-sized wheelchairs and gurneys to buses with bigger seats and stronger brakes, obese America is putting a heavy financial toll on the country’s health system. According to >> Full story


Nutella To Compensate American Consumers

NEW YORK – Americans who purchased the popular Nutella coco spread last year can expect the company to reimburse them to the tune of up to $US3 million. A California mother filed a lawsuit against >> Full story




 People who searched for avastin also checked these
RESOURCES:   Work From Home:
 
 


Nodeju.com Logo
Copyright 2010 Nodeju.com
All Rights Reserved
 NDJ WORLD
North America   Europe   Africa   South America   Asia   Australia

 TOPICS
Celebrities   Commentary   Health   Horror Files   Lifestyle   High Tech   Sports   Travel   Unusual

 GENERAL INFO
Contact NDJ   About Nodeju.com (NDJ)   NDJ Policies   Writers   Subscribe to RSS Feeds  
Advertise Here   Press Release